Abstract

Arginine vasopressin (AVP) and oxytocin (OXT) are pleiotropic hormones released from the neurohypophysis. We demonstrated that neurointermediate pituitary lobectomy (NIL) in rats significantly protects against experimental autoimmune encephalomyelitis (EAE), a demyelinating T cell‐mediated disease of the central nervous system (CNS), whereas administration of desmopressin (DP, an AVP synthetic analog), restores the susceptibility of the NIL animals to EAE. Since immune cells have AVP and OXT receptors, we investigated whether OXT beside AVP, has also an immunomodulatory role on EAE. A comparative study of the effects of NIL, NIL+ DP and NIL+ carbetocin (CBT, a synthetic OXT analog) on clinical symptoms of EAE and on the number of CNS infiltrating lymphocytes were assessed. Animals were immunized for EAE one week after starting the administration of DP and CBT. EAE clinical signs were evaluated daily and CNS lymphocytes were separated with Percoll gradient. In NIL rats DP restored susceptibility to EAE and increased lymphocytic infiltration in the CNS while CBT resulted in very mild EAE symptoms and no changes in CNS lymphocytes. In conclusion, AVP has more powerful immunomodulatory effects than OXT.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.